ID   CAPR1_RAT               Reviewed;         707 AA.
AC   Q5M9G3; A9ZSZ9; Q6YF16;
DT   08-APR-2008, integrated into UniProtKB/Swiss-Prot.
DT   08-APR-2008, sequence version 2.
DT   02-OCT-2024, entry version 104.
DE   RecName: Full=Caprin-1;
DE   AltName: Full=Cytoplasmic activation- and proliferation-associated protein 1;
DE   AltName: Full=GPI-anchored protein p137;
DE            Short=GPI-p137;
DE            Short=p137GPI;
DE   AltName: Full=RNA granule protein 105 {ECO:0000303|PubMed:15858068};
GN   Name=Caprin1; Synonyms=Gpiap1, Rng105 {ECO:0000303|PubMed:15858068};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, MRNA-BINDING,
RP   AND TISSUE SPECIFICITY.
RX   PubMed=15858068; DOI=10.1523/jneurosci.0382-05.2005;
RA   Shiina N., Shinkura K., Tokunaga M.;
RT   "A novel RNA-binding protein in neuronal RNA granules: regulatory machinery
RT   for local translation.";
RL   J. Neurosci. 25:4420-4434(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA] OF 1-70; 121-430 AND 518-686.
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 16-707.
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 21-707, AND INDUCTION.
RC   STRAIN=Sprague-Dawley; TISSUE=Fetal heart;
RX   PubMed=14565619; DOI=10.1002/bdra.10073;
RA   Collier J.M., Selmin O., Johnson P.D., Runyan R.B.;
RT   "Trichloroethylene effects on gene expression during cardiac development.";
RL   Birth Defects Res. A Clin. Mol. Teratol. 67:488-495(2003).
RN   [5]
RP   FUNCTION, SUBCELLULAR LOCATION, AND RNA-BINDING.
RX   PubMed=20516077; DOI=10.1074/jbc.m110.108944;
RA   Shiina N., Tokunaga M.;
RT   "RNA granule protein 140 (RNG140), a paralog of RNG105 localized to
RT   distinct RNA granules in neuronal dendrites in the adult vertebrate
RT   brain.";
RL   J. Biol. Chem. 285:24260-24269(2010).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: mRNA-binding protein that acts as a regulator of mRNAs
CC       transport, translation and/or stability, and which is involved in
CC       neurogenesis, synaptic plasticity in neurons and cell proliferation and
CC       migration in multiple cell types (PubMed:15858068, PubMed:20516077).
CC       Plays an essential role in cytoplasmic stress granule formation (By
CC       similarity). Acts as an mRNA regulator by mediating formation of some
CC       phase-separated membraneless compartment: undergoes liquid-liquid phase
CC       separation upon binding to target mRNAs, leading to assemble mRNAs into
CC       cytoplasmic ribonucleoprotein granules that concentrate mRNAs with
CC       associated regulatory factors (By similarity). Undergoes liquid-liquid
CC       phase separation following phosphorylation and interaction with FMR1,
CC       promoting formation of cytoplasmic ribonucleoprotein granules that
CC       concentrate mRNAs with factors that inhibit translation and mediate
CC       deadenylation of target mRNAs (By similarity). In these cytoplasmic
CC       ribonucleoprotein granules, CAPRIN1 mediates recruitment of CNOT7
CC       deadenylase, leading to mRNA deadenylation and degradation (By
CC       similarity). Binds directly and selectively to MYC and CCND2 mRNAs (By
CC       similarity). In neuronal cells, directly binds to several mRNAs
CC       associated with RNA granules, including BDNF, CAMK2A, CREB1, MAP2,
CC       NTRK2 mRNAs, as well as to GRIN1 and KPNB1 mRNAs, but not to rRNAs (By
CC       similarity). {ECO:0000250|UniProtKB:Q14444,
CC       ECO:0000269|PubMed:15858068, ECO:0000269|PubMed:20516077}.
CC   -!- ACTIVITY REGULATION: Ability to mediate liquid-liquid phase separation
CC       is regulated by ATP: moderate concentrations of ATP enhance phase
CC       separation, whereas high concentrations of ATP lead to inhibition of
CC       phase separation. {ECO:0000250|UniProtKB:Q14444}.
CC   -!- SUBUNIT: May form homomultimers. Interacts with G3BP1; interaction is
CC       direct and promotes stress granule formation. Interacts with G3BP2;
CC       interaction is direct and promotes stress granule formation. Interacts
CC       with PQBP1. Interacts with DDX3X. Interacts (when phosphorylated by
CC       EPHA4) with FMR1; interaction with FMR1 promotes formation of a
CC       membraneless compartment. {ECO:0000250|UniProtKB:Q14444}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, Cytoplasmic ribonucleoprotein granule
CC       {ECO:0000250|UniProtKB:Q14444}. Cytoplasm, cytosol
CC       {ECO:0000250|UniProtKB:Q14444}. Cell projection, dendrite
CC       {ECO:0000269|PubMed:15858068, ECO:0000269|PubMed:20516077}. Cell
CC       projection, lamellipodium {ECO:0000250|UniProtKB:Q14444}. Note=Mediates
CC       formation and localizes to cytoplasmic ribonucleoprotein membraneless
CC       compartments. Associated with RNA granules. At the leading edge of
CC       migrating fibroblasts, colocalizes with DDX3X.
CC       {ECO:0000250|UniProtKB:Q14444}.
CC   -!- TISSUE SPECIFICITY: Expressed in hippocampal and neocortical pyramidal
CC       neurons, but not in Purkinje cells. {ECO:0000269|PubMed:15858068}.
CC   -!- INDUCTION: Down-regulated by exposure to trichloroethylene (TCE) and
CC       dichloroethylene (DCE) in fetal heart. {ECO:0000269|PubMed:14565619}.
CC   -!- DOMAIN: The C-terminal disordered region undergoes liquid-liquid phase
CC       separation (LLPS) for the formation of a membraneless compartment that
CC       concentrates mRNAs with associated regulatory factors. CAPRIN1
CC       molecules in the condensed phase are neutral. mRNA-binding promotes
CC       phase separation. Moderate concentrations of ATP enhance phase
CC       separation by reducing the electrostatic potential of CAPRIN1, thereby
CC       promoting intermolecular interactions. In contrast, high concentrations
CC       of ATP invert the electrostatic potential of CAPRIN1, so that CAPRIN1
CC       molecules become negatively charged, lead to inhibition of phase
CC       separation. {ECO:0000250|UniProtKB:Q14444}.
CC   -!- PTM: Tyrosine phosphorylation by EPHA4 promotes interaction with FMR1
CC       and liquid-liquid phase separation (LLPS) for the formation of a
CC       membraneless compartment that concentrates mRNAs with associated
CC       regulatory factors. {ECO:0000250|UniProtKB:Q14444}.
CC   -!- PTM: O-glycosylated (O-GlcNAcylated), in a cell cycle-dependent manner.
CC       O-glycosylation by OGT inhibit ability to undergo liquid-liquid phase
CC       separation (LLPS). {ECO:0000250|UniProtKB:Q14444}.
CC   -!- SIMILARITY: Belongs to the caprin family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAO21306.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB373991; BAF98181.1; -; mRNA.
DR   EMBL; AABR03028010; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR03028081; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR03029653; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC087123; AAH87123.1; -; mRNA.
DR   EMBL; AY155572; AAO21306.1; ALT_INIT; mRNA.
DR   RefSeq; NP_001012185.2; NM_001012185.2.
DR   AlphaFoldDB; Q5M9G3; -.
DR   SMR; Q5M9G3; -.
DR   BioGRID; 263241; 3.
DR   IntAct; Q5M9G3; 2.
DR   MINT; Q5M9G3; -.
DR   STRING; 10116.ENSRNOP00000074604; -.
DR   GlyGen; Q5M9G3; 2 sites.
DR   iPTMnet; Q5M9G3; -.
DR   PhosphoSitePlus; Q5M9G3; -.
DR   jPOST; Q5M9G3; -.
DR   PaxDb; 10116-ENSRNOP00000012428; -.
DR   Ensembl; ENSRNOT00055000373; ENSRNOP00055000259; ENSRNOG00055000223.
DR   Ensembl; ENSRNOT00060002863; ENSRNOP00060001873; ENSRNOG00060001856.
DR   Ensembl; ENSRNOT00065029097; ENSRNOP00065023059; ENSRNOG00065017419.
DR   GeneID; 362173; -.
DR   KEGG; rno:362173; -.
DR   UCSC; RGD:1305707; rat.
DR   AGR; RGD:1305707; -.
DR   CTD; 4076; -.
DR   RGD; 1305707; Caprin1.
DR   VEuPathDB; HostDB:ENSRNOG00000009152; -.
DR   eggNOG; ENOG502QUGC; Eukaryota.
DR   InParanoid; Q5M9G3; -.
DR   OrthoDB; 5403347at2759; -.
DR   PhylomeDB; Q5M9G3; -.
DR   PRO; PR:Q5M9G3; -.
DR   Proteomes; UP000002494; Chromosome 3.
DR   Bgee; ENSRNOG00000009152; Expressed in spleen and 19 other cell types or tissues.
DR   ExpressionAtlas; Q5M9G3; baseline and differential.
DR   GO; GO:0031252; C:cell leading edge; ISS:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0010494; C:cytoplasmic stress granule; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IEA:UniProtKB-SubCell.
DR   GO; GO:0030425; C:dendrite; ISO:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0043232; C:intracellular non-membrane-bounded organelle; ISO:RGD.
DR   GO; GO:0030027; C:lamellipodium; IEA:UniProtKB-SubCell.
DR   GO; GO:0000932; C:P-body; IDA:UniProtKB.
DR   GO; GO:0098794; C:postsynapse; IDA:SynGO.
DR   GO; GO:0045202; C:synapse; ISO:RGD.
DR   GO; GO:0005524; F:ATP binding; ISS:UniProtKB.
DR   GO; GO:0140693; F:molecular condensate scaffold activity; ISS:UniProtKB.
DR   GO; GO:0140677; F:molecular function activator activity; ISO:RGD.
DR   GO; GO:0003729; F:mRNA binding; ISO:RGD.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProtKB.
DR   GO; GO:0035591; F:signaling adaptor activity; ISO:RGD.
DR   GO; GO:0048699; P:generation of neurons; ISO:RGD.
DR   GO; GO:0008298; P:intracellular mRNA localization; ISO:RGD.
DR   GO; GO:0017148; P:negative regulation of translation; IDA:UniProtKB.
DR   GO; GO:0007399; P:nervous system development; ISO:RGD.
DR   GO; GO:0140694; P:non-membrane-bounded organelle assembly; ISO:RGD.
DR   GO; GO:0050775; P:positive regulation of dendrite morphogenesis; ISS:UniProtKB.
DR   GO; GO:0061003; P:positive regulation of dendritic spine morphogenesis; ISS:UniProtKB.
DR   GO; GO:0062029; P:positive regulation of stress granule assembly; ISS:UniProtKB.
DR   GO; GO:0106288; P:regulation of deadenylation-dependent decapping of nuclear-transcribed mRNA; ISS:UniProtKB.
DR   GO; GO:0007416; P:synapse assembly; ISO:RGD.
DR   GO; GO:0050808; P:synapse organization; ISO:RGD.
DR   InterPro; IPR028816; Caprin.
DR   InterPro; IPR022070; Caprin-1_C.
DR   InterPro; IPR041637; Caprin-1_dimer.
DR   PANTHER; PTHR22922:SF3; CAPRIN-1; 1.
DR   PANTHER; PTHR22922; GPI-ANCHORED PROTEIN P137; 1.
DR   Pfam; PF12287; Caprin-1_C; 1.
DR   Pfam; PF18293; Caprin-1_dimer; 1.
PE   1: Evidence at protein level;
KW   Acetylation; ATP-binding; Cell projection; Coiled coil; Cytoplasm;
KW   Differentiation; Glycoprotein; Methylation; Nucleotide-binding;
KW   Phosphoprotein; Protein synthesis inhibitor; Reference proteome;
KW   RNA-binding.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:Q14444"
FT   CHAIN           2..707
FT                   /note="Caprin-1"
FT                   /id="PRO_0000327209"
FT   REGION          1..48
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          325..347
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          358..379
FT                   /note="G3BP1-binding"
FT                   /evidence="ECO:0000250|UniProtKB:Q14444"
FT   REGION          412..443
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          523..558
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          570..620
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          641..707
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          58..92
FT                   /evidence="ECO:0000255"
FT   COILED          123..151
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        1..22
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        325..342
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        530..558
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        570..607
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        641..677
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         2
FT                   /note="N-acetylproline"
FT                   /evidence="ECO:0000250|UniProtKB:Q14444"
FT   MOD_RES         10
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14444"
FT   MOD_RES         113
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14444"
FT   MOD_RES         163
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q60865"
FT   MOD_RES         333
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14444"
FT   MOD_RES         341
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14444"
FT   MOD_RES         623
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14444"
FT   MOD_RES         624
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14444"
FT   MOD_RES         631
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14444"
FT   MOD_RES         634
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14444"
FT   MOD_RES         637
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14444"
FT   MOD_RES         638
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14444"
FT   MOD_RES         649
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14444"
FT   MOD_RES         660
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14444"
FT   MOD_RES         663
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14444"
FT   MOD_RES         668
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14444"
FT   MOD_RES         696
FT                   /note="Asymmetric dimethylarginine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q14444"
FT   MOD_RES         696
FT                   /note="Omega-N-methylarginine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q14444"
FT   CARBOHYD        642
FT                   /note="O-linked (GlcNAc) serine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14444"
FT   CARBOHYD        647
FT                   /note="O-linked (GlcNAc) serine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14444"
FT   CONFLICT        27
FT                   /note="E -> K (in Ref. 4; AAO21306)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        48
FT                   /note="Q -> E (in Ref. 4; AAO21306)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        372
FT                   /note="Q -> Y (in Ref. 4; AAO21306)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        396
FT                   /note="T -> A (in Ref. 4; AAO21306)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        537
FT                   /note="S -> N (in Ref. 4; AAO21306)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        557
FT                   /note="T -> Q (in Ref. 4; AAO21306)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        571
FT                   /note="Y -> F (in Ref. 4; AAO21306)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        582
FT                   /note="P -> L (in Ref. 4; AAO21306)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        587..588
FT                   /note="QP -> AA (in Ref. 4; AAO21306)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   707 AA;  78121 MW;  3F0859BC83403242 CRC64;
     MPSATSHSGS GSKSSGPPPP SGSSGSEAAA GAAAPASQHP ATGTGAVQTE AMKQILGVID
     KKLRNLEKKK GKLDDYQERM NKGERLNQDQ LDAVSKYQEV TNNLEFAKEL QRSFMALSQD
     IQKTIKKTAR REQLMREEAE QKRLKTVLEL QYVLDKLGDD DVRTDLKQGL SGVPILSEEE
     LSLLDEFYKL VDPERDMSLR LNEQYEHASI HLWDLLEGKE KPVCGTTYKA LKEIVERVFQ
     SNYFDSTHNH QNGLCEEEEA ASAPIVEDQV AEAEPEPTEE YTEQSEVEST EYVNRQFMAE
     TQFSSGEKEQ VDEWAVETVE VVNSLQQQPQ AASPSVPEPH SLTPVAQSDP LVRRQRVQDL
     MAQMQGPYNF IQDSMLDFEN QTLDPAIVSA QPMNPTQNMD MPQLVCPQVH SESRLAQSNQ
     VPVQPEATQV PLVSSTSEGY TASQPLYQPS HAAEQRPQKE PIDQIQATIS LNTEQTTASS
     SLPAASQPQV FQAGASKPLH SSGINVNAAP FQSMQTVFNM NAPVPPVNEP ETLKQQSQYQ
     ASYNQSFSSQ PHQVEQTELQ QDQLQTVVGT YHGSQDQPHQ VPGNHQQPPQ QSTGFPRSSQ
     PYYNSRGVSR GGSRGARGLM NGYRGPANGF RGGYDGYRSS FSNTPNSGYT QSQFNAPRDY
     SGYQRDGYQQ NFKRGSGQSG PRGAPRGRGG PPRPNRGMPQ MNTQQVN
//
